In RE: Chemed Corporation, Shareholder Derivative Litigation
Case Number:
1:13-cv-01854
Court:
Nature of Suit:
Multi Party Litigation:
Derivative Litigation
Judge:
Firms
Companies
Sectors & Industries:
-
January 05, 2018
Investors Can't Prove It Knew Of Medicare Fraud: Chemed
Chemed Corp. on Friday asked a Delaware federal judge to again nix a shareholder-brought complaint alleging the company failed to prevent Medicare fraud, saying the shareholders still have no proof.
-
May 12, 2016
Hospice Care Execs Dodge Shareholders' Medicare Fraud Suit
A Delaware federal judge on Thursday dismissed investors' claims that current and former executives at Chemed Corp.'s hospice care business breached their duty to prevent Medicare fraud, saying the complaint doesn't spell out what the executives allegedly knew about the overbilling.
-
April 03, 2014
JPML Declines To Combine Chemed Shareholder Suits
The U.S. Judicial Panel on Multidistrict Litigation on Thursday declined to combine two shareholder derivative actions accusing Chemed Corp. and its executives of submitting various improper and ineligible claims to Medicare and Medicaid.